Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 71% · prior close shown (market closed)
Limited proprietary earnings coverage for MTNB yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 17d ago
MTNB's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on MTNB.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Matinas BioPharma Holdings, Inc. (MTNB) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
MTNB's AI investment thesis
Upgrade to Premium for MTNB's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$0.17
Market cap
$2.56M
Profitable
No
Revenue $1.10M
Net income
$-10.35M
FY Dec 31, 2023
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Matinas BioPharma Holdings, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Matinas BioPharma Holdings, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.